How to Apply for the 2018 ALK-Positive Lung Cancer Transformational Research Award

Alk PositiveALK Positive, a group of 700+ ALK-positive patients and their caregivers who have raised significant funds for research, and LUNGevity Foundation are partnering to support high-impact research that seeks to transform the future for patients affected by ALK-positive non-small cell lung cancer. This is the first group of ALK-positive patients to directly influence the direction of research that will, one day, save their lives.

The project to be funded is expected to have a direct impact on the outcomes of patients with ALK-positive lung cancer, but innovative proposals that address other unmet needs in the ALK-positive lung cancer space are also invited for submission. Applicants are encouraged to propose projects that utilize the resources of the ALK Positive members, which include their available histories, opinions, tissues, bodily fluids, and any other aspects of their condition.

This award is open to researchers at both US and international institutions. Note that, at the time of application, international applicants must name a co-investigator at a US institution. All research funds will be disbursed through a US institution.

An applicant may submit no more than two applications for this award.

2018 ALK-Positive Research Award

  • $50,000 in each of four 6-month periods
  • 6-month milestones must be met

Letter of Intent Deadline: Tuesday, January 16, 2018 (11:59 pm EST)

Download RFA

The award may be for a maximum of $200,000:

  • $50,000 in each of four 6-month periods
  • 6-month milestones must be met

A two-step application process will be used:

  1. A letter of intent (LOI), with a brief overview of the proposed project and biographical information of the applicant  (and the applicant’s co-investigator at a U.S. institution, if the applicant is international)
  2. A full application with an extended narrative about the project as well as supporting information and documentation. Because there is only one award, only a subset of applicants is invited to submit a full application after the LOI review is completed.

Reviewers are drawn from the LUNGevity Scientific Advisory Board and other ALK experts.

Awardees have progress and financial reporting obligations during the award term.

Complete instructions and award details are included in the 2018 ALK-Positive Lung Cancer Transformation Award Request for Application. LOIs and full applications must be submitted electronically via proposalCENTRAL.

Timeline

LOI(s) due: By Tuesday, January 16, 2018 (11:59 pm EST)
Full application invitation: No earlier than Wednesday, February 21, 2018
Full application due (by invitation only): By Friday, March 23, 2018 (11:59 pm EST)
Award announcement: April 2018
Anticipated initial funding disbursement: Upon full execution of the agreement document

 

print